Manic episode, severe, without psychotic symptoms
Methodology & AI Transparency ⓘ
Manic episode, severe, without psychotic symptoms Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Within Depression, Bipolar & Mood Disorders practice, Manic episode, severe, without psychotic symptoms (ICD-10 F30.13) is stratified through sleep-wake rhythm assessment [Manic episode, severe, without psychotic symptoms F30.13], pairing targeted symptom control with longitudinal TSH & Free in Manic episode, severe, without psychotic symptoms (F30.13: T4 Rule-Out) surveillance.
- 2 Real-world patient consensus: Federal ICD-10-CM code F30.13 categorizes Manic episode, severe, without psychotic symptoms under Depression, Bipolar & Mood Disorders.
- 3 Typical cash cost range: Workup highlights for Manic episode, severe, without psychotic symptoms (F30.13): sleep-wake rhythm assessment [Manic episode, severe, without psychotic symptoms F30.13].
- 4 Top reported side effects / signs: Objective lab/clinical target for Manic episode, severe, without psychotic symptoms: PHQ-9 Symptom Severity in Manic episode, severe, without psychotic symptoms (F30.13: Score) (< 4 (clinical remission) (F30.13)) and TSH & Free in Manic episode, severe, without psychotic symptoms (F30.13: T4 Rule-Out).
Ask our AI Specialists anything about Manic episode, severe, without psychotic symptoms
What Is Manic episode, severe, without psychotic symptoms?
Within Depression, Bipolar & Mood Disorders practice, Manic episode, severe, without psychotic symptoms (ICD-10 F30.13) is stratified through sleep-wake rhythm assessment [Manic episode, severe, without psychotic symptoms F30.13], pairing targeted symptom control with longitudinal TSH & Free in Manic episode, severe, without psychotic symptoms (F30.13: T4 Rule-Out) surveillance.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in depression & mood, Manic episode, severe, without psychotic symptoms (F30.13) involves monoaminergic (serotonin [Manic episode, severe, without psychotic symptoms F30.13]. progression correlates with shifts in PHQ-9 Symptom Severity in Manic episode, severe, without psychotic symptoms (F30.13: Score) (< 4 (clinical remission) (F30.13)).
Common Symptoms & Clinical Signs
- • Presentation of Manic episode, severe, without psychotic symptoms (F30.13): loss of interest in Manic episode, severe, without psychotic symptoms (F30.13: or pleasure in)
- • Secondary Manic episode, severe, without psychotic symptoms clinical sign: persistent low mood, in Manic episode, severe, without psychotic symptoms (F30.13: emotional flatness, or)
- • Symptom flares in Manic episode, severe, without psychotic symptoms correlating with PHQ-9 Symptom Severity in Manic episode, severe, without psychotic symptoms (F30.13: Score) deviation outside < 4 (clinical remission) (F30.13)
- • Functional depression & mood impact requiring sleep-wake rhythm assessment [Manic episode, severe, without psychotic symptoms F30.13] evaluation (F30.13)
Manic episode, severe, without psychotic symptoms Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F30.13 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Depression, Bipolar & Mood Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: PHQ-9 Symptom Severity in Manic episode, severe, without psychotic symptoms (F30.13: Score) | < 4 (clinical remission) (F30.13) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Free in Manic episode, severe, without psychotic symptoms (F30.13: T4 Rule-Out) | TSH 0.8 – 2.5 mIU/L (F30.13) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin D in Manic episode, severe, without psychotic symptoms (F30.13: & RBC Folate) | 25(OH)D 40 – 65 ng/mL (F30.13) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Manic episode, severe, without psychotic symptoms
Treatment selection for Manic episode, severe, without psychotic symptoms depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Manic episode, severe, without psychotic symptoms)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Pharmacological and non-pharmacological treatments for depression in: What a 10,991-Participant Study Found Herbal medicine and mirtazapine had no significant difference in overall risk of side effects compared with placebo. Psychiatry research • 2019-11-15 • Meta-Analysis | N = 10,991 | 99/100 | PMID 31627074 ↗ |
| New Insights on Benefits and safety of bupropion hydrochloride extended-release versus: What a 538-Participant Study Found Results from this study demonstrated that the efficacy of bupropion XL was non-inferior to that of escitalopram in Chinese patients with MDD. Journal of affective disorders • 2019-10-01 • Randomized Controlled Trial | N = 538 | 93/100 | PMID 31301615 ↗ |
| New Insights on Effect of next-step antidepressant treatment on suicidal ideation: findings from: What a 1,522-Participant Study Found SI declines for most patients during next-step medication treatments. Psychological medicine • 2024-04-15 • Randomized Controlled Trial | N = 1,522 | 90/100 | PMID 37859623 ↗ |
| Can This Approach Help? Inside the Latest Research on Sexual function during bupropion or paroxetine treatment of According to the Sex FX scale, a significant difference in antidepressant-related sexual dysfunction was detected in men, but not women, during treatment with bupropion SR or paroxetine. Canadian journal of psychiatry. Revue canadienne de psychiatrie • 2006-03-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 16629348 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of adjunctive cariprazine on symptoms of anhedonia in patients with In patients with MDD and moderate-to-severe anhedonia, adjunctive cariprazine improved symptoms of general depression and anhedonia, suggesting a potential benefit for patients with this clinically significant symptom. Journal of affective disorders • 2025-09-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40339720 ↗ |
Manic episode, severe, without psychotic symptoms Patient Community & “People Like Me” Threads
Filter Manic episode, severe, without psychotic symptoms community threads and patient logs by age, biological sex, dosage, and treatment duration.